Navigation Links
Amedica® Closes $30 Million Financing

SALT LAKE CITY, Sept. 7 /PRNewswire/ -- Amedica Corporation, a developer of a broad range of innovative, unique spine and total joint implants, announced that it has completed a $30 million financing.  The financing consists of $15 million in private equity and a debt facility of $15 million.  Zions First National Bank provided the debt facility, and Creation Capital of New York and Austin, Texas, acted as the placement agent for the private equity piece.  Creation Capital is an established banking concern that specializes in high-growth emerging health care technologies.

The proceeds from this financing will be used for expansion, mergers and acquisitions, sales and marketing support.  Ben Shappley, Chief Executive Officer, President and Director of Amedica stated, "We are pleased to complete this transaction that will enable and further sustain our substantial growth.  We are currently experiencing a challenging period in the capital markets and the overall struggling economy.  Our success in completing this and other recent strategic financings clearly speaks to the importance of our platform technologies, our vast intellectual property estate and investor confidence in the strength of our organization."

Amedica has completed transactions in excess of $100 million in the recent past to support and grow the company's technology assets and value.  Amedica has shown solid growth at a CAGR of 24% increase over the last six quarters in its spinal implant business.  

About Amedica:

Amedica Corporation is ISO 13485 certified and its products are FDA cleared and CE approved.  Amedica Corporation is an emerging orthopaedic implant company focused on using its silicon nitride ceramic and other technologies to develop and commercialize a broad range of innovative, unique spine and total joint implants for the growing orthopaedic device market.  It has brought to market various spinal implant products, while products under development include reconstructive hip and knee implants that represent a new standard of care in total joint implants based on superior performance, safety and efficacy.

SOURCE Amedica Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component
2. Amedica® Receives Patent for Hip Implant Using Monoblock Ceramic Technology
3. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
4. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
5. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
6. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
7. RoundTable Healthcare Partners Closes Two Funds
8. iPierian Closes $22 Million Series B Financing Led By Google Ventures
9. Micromet Closes $80.5 Million Public Offering of Common Stock
10. Cheetah Medical Closes $20 Million Series B Financing
11. Castle Access Closes Equity Capital Financing to Provide for Accelerated Growth
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):